Base excision repair

Pathway network for the Base excision repair SuperPath

Sources:
  • WikiPathways
  • Reactome
  • GeneGo (Thomson Reuters)
  • QIAGEN

Pathways in the Base excision repair SuperPath

#NameSourceGenes
1Base excision repairWikiPathways
2Resolution of Abasic Sites (AP sites)Reactome
3Cell cycle Transition and termination of DNA replicationGeneGo (Thomson Reuters)
4Resolution of AP sites via the multiple-nucleotide patch replacement pathwayReactome
5Gap-filling DNA repair synthesis and ligation in GG-NERReactome
6DNA mismatch repairWikiPathways
7PCNA-Dependent Long Patch Base Excision RepairReactome
8Mismatch Repair in EukaryotesQIAGEN
9Displacement of DNA glycosylase by APEX1Reactome
10POLB-Dependent Long Patch Base Excision RepairReactome
11APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement PathwayReactome
12Resolution of AP sites via the single-nucleotide replacement pathwayReactome
13Abasic sugar-phosphate removal via the single-nucleotide replacement pathwayReactome

Gene overlap in member pathways for Base excision repair SuperPath

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

Disorders associated with Base excision repair SuperPath

according to GeneCards Suite gene sharing
#DisorderTypeGenesScore
1Mismatch repair cancer syndrome 1EnrichmentMLH1, MSH2, MSH6, PMS211.19
2Colorectal cancerEnrichmentMLH1, MSH2, MSH6, PMS1, PMS2, POLD1, POLE10.71
3Lynch syndromeEnrichmentMLH1, MSH2, MSH6, PMS1, PMS210.63
4Endometrial cancerEnrichmentMLH1, MSH2, MSH3, MSH6, PMS210.01
5Inherited cancer-predisposing syndromeEnrichmentMLH1, MSH2, MSH3, MSH6, PMS2, POLD1, POLE9.30
6Lynch syndrome 1EnrichmentMLH1, MSH2, MSH6, PMS29.15
7Lynch syndrome 4EnrichmentMSH2, MSH6, PMS27.96
8Gastric cancerEnrichmentMLH1, MSH2, MSH6, PMS26.39
9Hereditary breast ovarian cancer syndromeEnrichmentMLH1, MSH2, MSH6, PMS25.95
10RhabdomyosarcomaEnrichmentMSH2, MSH6, PMS25.82
11Familial colorectal cancer type xEnrichmentMUTYH, POLD1, POLE5.75
12Muir-torre syndromeEnrichmentMLH1, MSH25.69
13Breast cancerEnrichmentMLH1, MSH2, MSH6, PMS25.41
14Polymerase proofreading-related polyposisEnrichmentPOLD1, POLE5.21
15Ovarian cancerEnrichmentMSH2, MSH6, PMS1, PMS24.89
16Hereditary breast carcinomaEnrichmentMLH1, MSH2, MSH64.46
17Familial colorectal cancerEnrichmentMLH1, MSH24.03
18Uterine corpus cancerEnrichmentMSH2, MSH63.95
19Spinocerebellar ataxia, autosomal recessive 26EnrichmentXRCC13.53
20Ataxia-oculomotor apraxia 4EnrichmentPNKP3.29
21Mitochondrial dna depletion syndrome 20EnrichmentLIG33.23
22Immunodeficiency 96EnrichmentLIG13.23
23Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizuresEnrichmentADPRS3.23
24Melanoma, uveal 1EnrichmentMBD43.18
25Familial adenomatous polyposis 3EnrichmentNTHL13.18
26Tumor predisposition syndrome 2EnrichmentMBD43.18
27Charcot-marie-tooth disease, axonal, type 2b2EnrichmentPNKP2.99
28Congenital disorder of deglycosylation 2EnrichmentNEIL12.99
29Charcot-marie-tooth disease type 2b2EnrichmentPNKP2.99
30Microcephaly, seizures, and developmental delayEnrichmentPNKP2.99
31Familial adenomatous polyposis 2EnrichmentMUTYH2.88
32Immunodeficiency with hyper-igm, type 5EnrichmentUNG2.88
33Cystic fibrosis with helicobacter pylori gastritis, megaloblastic anemia, and impaired intellectual developmentEnrichmentPOLE2.83
34Van esch-o'driscoll syndromeEnrichmentPOLA12.83
35Colorectal cancer 10EnrichmentPOLD12.83
36Colorectal cancer 12EnrichmentPOLE2.83
37Pigmentary disorder, reticulate, with systemic manifestations, x-linkedEnrichmentPOLA12.83
38Leukodystrophy, hypomyelinating, 27EnrichmentPOLR1A2.83
39Immunodeficiency 120EnrichmentPOLD12.83
40Lynch syndrome 2EnrichmentMLH12.83
41Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndromeEnrichmentPOLD12.83
42Ataxia-telangiectasia-like disorder 2EnrichmentPCNA2.83
43Mismatch repair cancer syndrome 2EnrichmentMSH22.83
44Mismatch repair cancer syndrome 4EnrichmentPMS22.83
45Rectal benign neoplasmEnrichmentMSH22.83
46Pituitary cancerEnrichmentPMS22.83
47Ascending colon cancerEnrichmentMSH22.83
48Morimoto-ryu-malicdan neuromuscular syndromeEnrichmentRFC42.83
49Ovarian cystEnrichmentMSH22.83
50Pulmonary fibrosis and/or bone marrow failure syndrome, telomere-related, 6EnrichmentRPA12.81
51Immunodeficiency 122EnrichmentPOLD32.81
52Spastic paraplegia 7, autosomal recessiveEnrichmentMUTYH2.70
53Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemiaEnrichmentPNKP2.69
54Developmental and epileptic encephalopathy 12EnrichmentPNKP2.69
55Pancreatic cancerEnrichmentBRCA1, POLD12.66
56Brachyphalangy, polydactyly, and tibial aplasia/hypoplasiaEnrichmentHMGB12.64
57PilomatrixomaEnrichmentMUTYH2.58
58Mitochondrial neurogastrointestinal encephalomyopathyEnrichmentLIG32.58
59Palmoplantar keratoderma, punctate type iiEnrichmentBRCA12.55
60B-cell immunodeficiency, distal limb anomalies, and urogenital malformationsEnrichmentTOP2B2.55
61Infant-type hemispheric gliomaEnrichmentBRCA12.55
62Deafness, autosomal dominant 70EnrichmentMCM22.55
63Primary peritoneal carcinomaEnrichmentBRCA12.55
64Burkitt lymphomaEnrichmentPMS22.53
65Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomaliesEnrichmentPOLE2.53
66Cerebellar ataxia, neuropathy, and vestibular areflexia syndromeEnrichmentRFC12.53
67Intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, genital anomalies, and immunodeficiencyEnrichmentPOLE2.53
68Facial dysmorphism, immunodeficiency, livedo, and short statureEnrichmentPOLE2.53
69Acrofacial dysostosis, cincinnati typeEnrichmentPOLR1A2.53
70Mismatch repair cancer syndrome 3EnrichmentMSH62.53
71Clear cell renal cell carcinomaEnrichmentOGG12.51
72Familial adenomatous polyposis 1EnrichmentMUTYH2.48
73Hereditary clear cell renal cell carcinomaEnrichmentOGG12.44
74Neurodevelopmental disorder with hypotonia, speech delay, and dysmorphic faciesEnrichmentPOLK2.43
75Submucosal cleft palateEnrichmentUBB2.43
76Cleft hard palateEnrichmentUBB2.43
77Partington syndromeEnrichmentPOLA12.35
78Burn-mckeown syndromeEnrichmentPOLR1A2.35
79Lynch syndrome 5EnrichmentMSH62.35
80Familial adenomatous polyposis 4EnrichmentMSH32.35
81Cellular ependymomaEnrichmentMSH22.35
82Tanycytic ependymomaEnrichmentMSH22.35
83Papillary ependymomaEnrichmentMSH22.35
84Childhood apraxia of speechEnrichmentRFC32.35
85Intellectual developmental disorder with dysmorphic facies and behavioral abnormalitiesEnrichmentMSH62.35
86Colon adenocarcinomaEnrichmentMSH62.35
87Clear cell ependymomaEnrichmentMSH22.35
88Uvula, bifidEnrichmentUBB2.26
89Cleft soft palateEnrichmentUBB2.26
90Progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive 2EnrichmentRNASEH12.25
91Fanconi anemia, complementation group sEnrichmentBRCA12.25
92Werner syndromeEnrichmentWRN2.25
93Pancreatic cancer 4EnrichmentBRCA12.25
94Primordial dwarfism-immunodeficiency-lipodystrophy syndromeEnrichmentPRIM12.25
95Inflammatory breast carcinomaEnrichmentBRCA12.25
96Peritoneum cancerEnrichmentBRCA12.25
97Bilateral breast cancerEnrichmentBRCA12.25
98Gaucher disease, type iEnrichmentMSH62.23
99Benign ependymomaEnrichmentMSH22.23
100Colonic benign neoplasmEnrichmentMUTYH2.22
101Breast-ovarian cancer, familial 2EnrichmentPMS22.13
102LymphomaEnrichmentPMS22.13
103GlioblastomaEnrichmentMSH22.13
104Renal cell carcinoma, nonpapillaryEnrichmentOGG12.11
105Isolated congenital microcephalyEnrichmentPNKP2.08
106Early infantile developmental and epileptic encephalopathyEnrichmentPNKP2.03
107Polyposis syndrome, hereditary mixed, 1EnrichmentBRCA11.95
108CholangiocarcinomaEnrichmentBRCA11.95
109Cardiomyopathy, familial hypertrophic, 9EnrichmentPMS21.79
110Combined immunodeficiencyEnrichmentPOLD11.79
111Combined t cell and b cell immunodeficiencyEnrichmentPOLD11.79
112Combined t and b cell immunodeficiencyEnrichmentPOLD11.79
113Breast-ovarian cancer, familial 1EnrichmentMSH21.72
114GliosarcomaEnrichmentMSH21.63
115Giant cell glioblastomaEnrichmentMSH21.61
116Diffuse large b-cell lymphomaEnrichmentPMS21.56
117Parkinson's diseaseEnrichmentRFC11.56
118Williams-beuren syndromeEnrichmentRFC21.54
119HepatoblastomaEnrichmentMSH21.52
120Hepatocellular carcinomaEnrichmentPMS21.50
121Cardiomyopathy, dilated, 1gEnrichmentPMS21.50
122Parkinson disease, late-onsetEnrichmentRFC11.46
123MedulloblastomaEnrichmentWRN1.41
124Periventricular nodular heterotopiaEnrichmentBRCA11.41
125Seckel syndromeEnrichmentPRIM11.41
126CataractEnrichmentWRN1.41
127Prostate cancerEnrichmentMSH61.38
128Lung cancerEnrichmentMLH11.34
129Congenital nervous system abnormalityEnrichmentPNKP1.27
130Nervous system diseaseEnrichmentPNKP1.27
131Bladder cancerEnrichmentBRCA11.11
132Fanconi anemia, complementation group aEnrichmentBRCA11.03
133Type 2 diabetes mellitusEnrichmentWRN0.95
134Rare autosomal dominant non-syndromic sensorineural deafness type dfnaEnrichmentMCM20.87
135Myeloma, multipleEnrichmentBARD10.84
136Autism spectrum disorderEnrichmentTOP2B0.58

Loading...
Loading...
Loading...